Effects of N¹-methylnicotinamide on oxidative and glycooxidative stress markers in rats with streptozotocin-induced diabetes mellitus

References

• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–20.
   PubMed Web of Science ®Google Scholar
• Van Dam PS, Van Asbek BS, Erkelens BW, Marx JJM, Gispen WH, Brevenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev 1995;11:181–92.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 2008;14(10):962–8.
   PubMed Web of Science ®Google Scholar
• Muchová J, Liptáková A, Országhová Z, Garaiová I, Tisoň P, Čársky J, et al. Antioxidant systems in polymorphonuclear leucocytes of type 2 diabetes mellitus. Diabet Med 1999;16(1):74–8.
   PubMed Web of Science ®Google Scholar
• Boušová I, Martin J, Jahodář L, Dušek J, Palička V, Dršata J. Evaluation of in vitro effects of natural substances of plant origin using a model of protein glycoxidation. J Pharm Biomed Anal 2005;37:957–62.
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000;28:1708–16.
   PubMed Web of Science ®Google Scholar
• Sartini D, Santarelli A, Rossi V, Goteri G, Rubini C, Ciavarella D, et al. Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol Med 2007;13:415–21.
   PubMed Web of Science ®Google Scholar
• Williams AC, Ramsden DB. Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases. Med Hypotheses 2005;65:353–62.
   PubMed Web of Science ®Google Scholar
• Klaidman L, Morales M, Kem S, Yang J, Chang ML, Adams JD. Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology 2003;69:150–7.
   PubMed Web of Science ®Google Scholar
• O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis. J Pathol 2000;191:86–92.
   PubMed Web of Science ®Google Scholar
• Aoyama K, Matsubara K, Okada K, Fukushima S, Shimizu K, Yamaguchi S, et al. N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test. J Neural Transm 2000;107:985–95.
   PubMed Web of Science ®Google Scholar
• Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A. Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol 2005;30:632–5.
   PubMed Web of Science ®Google Scholar
• Gebicki J, Sysa-Jedrzejowska A, Adamus J, et al. 1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. Pol J Pharmacol 2003;55:109–12.
   PubMedGoogle Scholar
• Fischer LJ, Falany J, Fisher R. Characteristics of nicotinamide and N1-methylnicotinamide protection from alloxan diabetes in mice. Toxicol Appl Pharmacol 1983;70:148–55.
   PubMed Web of Science ®Google Scholar
• Adamiec M, Adamus J, Ciebiada I, Denys A, Gebicki J. Search for drugs of the combined anti-inflammatory and anti-bacterial properties: 1-methyl-N’-(hydroxymethyl) nicotinamide. Pharmacol Rep 2006;58:246–9.
   PubMed Web of Science ®Google Scholar
• Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartus M, Lomnicka M, et al. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts antithrombotic activity mediated by COX-2/PGI2 pathway. Br J Pharmacol 2007;152:230–9.
   PubMed Web of Science ®Google Scholar
• Ogata S, Takeuchi M, Teradaira S, Yamamoto N, Iwata K, Okumura K, et al. Radical scavenging activities of niacin-related compounds. Biosci Biotechnol Biochem 2002;66(3):641–5.
   PubMed Web of Science ®Google Scholar
• Shaw EN. Quaternary pyridinium compounds. In: , Klingsberg E (ed.) Pyridine and its derivatives. New York: Interscience Publishers; 1961. p. 1–31.
   Google Scholar
• Kalousová M, Škrha J, Zíma T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51:597–604.
   PubMed Web of Science ®Google Scholar
• El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627–30.
   PubMed Web of Science ®Google Scholar
• Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn ChC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997;23(3):361–6.
   PubMed Web of Science ®Google Scholar
• Collins AR, Duthie SJ, Dobson VL. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993;14:1733–5.
   PubMed Web of Science ®Google Scholar
• Collins AR, Dobson VL, Dušinská M, Kennedy G, Štetina R. Comet assay: what can it really tell us? Mutat Res 1997;375:183–93.
   PubMed Web of Science ®Google Scholar
• , ESCODDGedik CM, Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J 2004;18:1–23.
   PubMedGoogle Scholar
• Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26(9/10):1231–7.
   PubMed Web of Science ®Google Scholar
• Gale EA, Bingley PJ, Emmett CL, Collier T, European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004;363(9413):925–31.
   PubMed Web of Science ®Google Scholar
• Biedroń R, Ciszek M, Tokarczyk M, Bobek M, Kurnyta M, Słominska EM, et al. 1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages. Arch Immunol Ther Exp 2008;56:127–34.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Thornalley PJ. Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans 2003;31(6):1417–22.
   PubMed Web of Science ®Google Scholar
• Watała C, Kaźmierczak P, Dobaczewski M, Przygodzki T, Bartus M, Lomnicka M, et al. Anti-diabetic effects of 1-methylnicotinamide (MNA) in streptozocin-induced diabetes in rats. Pharmacol Rep 2009;61:86–98.
   PubMed Web of Science ®Google Scholar
• Pan HZ, Zhang H, Chang D, Li H, Sui H. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 2008;92:548–51.
   PubMed Web of Science ®Google Scholar
• Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 2005;31:551–7.
   PubMed Web of Science ®Google Scholar
• Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 2002;251:69–76.
   PubMed Web of Science ®Google Scholar
• Willems D, Dorchy H, Dufrasne D. Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications. Atherosclerosis 1998;137:61–4.
   Web of Science ®Google Scholar
• Feillet C, Roche B, Tauveron I, Bayle D, Rock E, Borel P, et al. Susceptibility to oxidation and physicochemical properties of LDL in insulin-dependent diabetics. Atherosclerosis 1998;136:405–7.
   PubMed Web of Science ®Google Scholar
• Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444–5.
   PubMed Web of Science ®Google Scholar
• Collins AR, Rašlová K, Somorovská M, Petrovská H, Ondrušová A, Vohnout B, et al. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med 1998;25(3):373–7.
   PubMed Web of Science ®Google Scholar